Trials Sponsors Conditions Drugs Pricing

Conditions

Pancreatic

Outcome Measures

Primary Outcomes (2)

Characterization of proteins in tumor exosomes from patients with pancreatic cancer
We will select specific protein A from circulating exosomes of pancreatic cancer patients for further analysis.
Up to 2 years from start of study
The expression of protein A in the circulating exosomes from patients
By detecting the expression of protein A in circulating exosomes of patients. the ROC curve of A+ circulating exosomes will be compared to clinical standard tumor biomarkers (e.g., CA199) in pancreatic cancer patients.
Up to 2 years from start of study

Study Arms (2)

pancreatic patients

Cases will be the patients with newly-diagnosed pancreatic.

The controls

Controls will be selected from patients with pancreatitis from the same hospital as the case, matched by gender, race and age (1:1).

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Cases will be patients with newly diagnosed pancreatic cancer. Controls will be selected from patients with pancreatitis in the same hospital as the cases, matched by sex, race and age (1:1). A total of 400 patients with gallbladder cancer will be recruited.

You may qualify if:

Diagnosis of pancreatic cancer confirmed by imaging (case) Diagnosis of chronic pancreatitis confirmed by imaging (hospital control)

Sponsors & Collaborators

Shanghai Jiao Tong University School of Medicine
Otherlead

Study Sites (1)

Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine

Shanghai, Shanghai Municipality, 20092, China

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: vice-president，Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Study Record Dates

First Submitted

October 23, 2023

First Posted

October 31, 2023

Study Start

November 1, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

pancreatic patients

The controls

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

pancreatic patients

The controls

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations